VIVUS, Inc.
(NASDAQ : VVUS)

( )
VVUS PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
Loading VVUS News...
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc.
3.09%16.6810.2%$225.31m
SHPGShire PLC Sponsored ADR
0.88%182.880.3%$189.99m
PRGOPerrigo Co. Plc
0.27%84.664.3%$136.99m
MNKMallinckrodt Plc
2.27%54.5911.1%$114.80m
MDCOMedicines Company
2.23%53.2219.0%$112.73m
ENDPEndo International Plc
1.07%13.299.0%$92.81m
UTHRUnited Therapeutics Corporation
3.95%152.5112.7%$87.16m
PRXLPAREXEL International Corporation
0.49%66.267.5%$86.69m
ICPTIntercept Pharmaceuticals, Inc.
4.77%124.8721.9%$77.68m
JAZZJazz Pharmaceuticals Plc
0.63%136.972.3%$66.57m
SAGESAGE Therapeutics, Inc.
10.45%68.8112.1%$53.28m
PTLAPortola Pharmaceuticals, Inc.
4.45%34.998.8%$48.67m
GWPHGW Pharmaceuticals PLC Sponsored ADR
1.35%125.4110.9%$48.64m
SGYPSynergy Pharmaceuticals, Inc.
7.83%5.9216.1%$42.20m
HZNPHorizon Pharma plc
-5.56%16.4811.1%$41.77m

Company Profile

VIVUS, Inc. operates as a biopharmaceutical company, which develops innovative, next-generation therapies to address unmet needs in obesity, diabetes, sleep apnea and sexual health. The company's products include Qsymia Obesity, Qsymia Sleep Apnea, Qsymia Diabetes and Avanafil. The company was founded by Virgil A. Place on May 24, 1996 and is headquartered in Mountain View, CA.